Stem cell liver model reproduces rare immune drug reactions
A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients.
List view / Grid view
A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients.
Researchers have made surprising and important findings that may influence organoid and cell reprogramming studies.
New research from Cincinnati Children’s Hospital Medical Center suggests blocking IL-22 and IL-1R could offer a promising IBD treatment.
An Ebola vaccine that has been tested in animals could potentially be used to neutralise four species of the virus, say the researchers.
A study has found a new molecular process in mice that causes autoimmune diseases and has opened avenues for developing more effective autoimmune therapies.
Researchers have discovered a protein that is required for T cell biological processes; they have also demonstrated the mechanism behind the protein.
Scientists have discovered a molecular pathway that contributes to PAH development, which may lead to a new drug target for the disease.
Researchers used a bioinformatic tool to suggest that circadian timing could be key to the success of certain drugs or therapies...
Researchers are hopeful of finding a means to inhibit obesity and its associated health problems after a study in which they blocked an RNA-silencing protein in the livers of mice, preventing obesity and diabetic conditions.
EBV may trigger some cases of lupus, say NIH-supported researchers...
Scientists have described an experimental molecular therapy that restores insulation on peripheral nerves in mice, improves limb function, and results in less observable discomfort...
Scientists discovered how a gene mutation affects T cell function to promote immune disorders...